Full study details emerge: spray reduced amyloid-beta and neuroinflammation
2 Sep 15 9:08 PM · 8d ago · 5 articles · 1 post · 3 sources · development 2 of 2
ScienceAlert published comprehensive coverage showing the nasal spray significantly reduced amyloid-beta deposits in the hippocampus and lowered neuroinflammation by reducing activation of astrocytes and microglia. Behavioral tests confirmed improved object recognition and spatial memory in treated mice, while separate experiments on human Alzheimer's patient-derived neurons showed the EV treatment reduced neuronal deterioration.
“MSC-derived EVs (MSC-EVs) are nanoparticles that mediate intercellular communication and have been demonstrated to potentially deliver bioactive molecules with anti-inflammatory and neuroprotective properties.”
Andrea Papait, lead authorAndrea Papait Lead author, cell biologistCatholic University of the Sacred Heart Research institution
The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump
Reported in the same hours no headline names this development itself — these 1 claim were published in its stretch
-
first by Technology Networks, 8d ago · also Drug Target Review, ScienceAlert, Eurasia Review
4 more headlines
- Nasal spray protects neurons and memory in Alzheimer's mouse model medicalxpress.com · 8d ago
- Nasal spray delivers amniotic vesicles to combat Alzheimer’s disease Drug Target Review · 8d ago
- Nasal Spray Derived From Human Placenta Protects Against Alzheimer's Decline, Study in Mice Shows ScienceAlert · 8d ago
- Alzheimer’s: A Nasal Spray Protects Neurons And Memory Eurasia Review · 5d ago
All 2 developments of Placenta-derived nasal spray shows promise against… →
RedditNewswiresMastodonGoogle News